Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Keycorp Pref F | KEY-J | Apr 30, 2024 | 20.57 | -0.77 |
Keycorp Pref G | KEY-K | Apr 30, 2024 | 20.62 | +0.15 |
Keysight Technologies | KEYS | Apr 30, 2024 | 147.94 | -1.51 |
Kezar Life Sciences | KZR | Apr 30, 2024 | 0.82 | -1.59 |
KFA Global Carbon ETF | KRBN | Apr 30, 2024 | 32.50 | +2.59 |
Kforce | KFRC | Apr 30, 2024 | 61.76 | -3.85 |
Kidpik | PIK | Apr 30, 2024 | 3.82 | -4.74 |
Kilroy Realty | KRC | Apr 30, 2024 | 33.80 | -1.72 |
Kimball Electronics | KE | Apr 30, 2024 | 20.93 | -2.97 |
Kimbell Royalty Partners LP Units | KRP | Apr 30, 2024 | 15.84 | -2.10 |
Kimberly-Clark | KMB | Apr 30, 2024 | 136.53 | +0.44 |
Kimco Realty | KIM | Apr 30, 2024 | 18.63 | -0.96 |
Kimco Realty L Pref | KIM-L | Apr 30, 2024 | 21.67 | -1.19 |
Kimco Realty M Pref | KIM-M | Apr 30, 2024 | 22.23 | -1.81 |
Kimco Realty Pref ADR | KIM-N | Apr 30, 2024 | 55.18 | 0.00 |
Kinder Morgan | KMI | Apr 30, 2024 | 18.28 | -1.72 |
Kineta | KA | Apr 30, 2024 | 0.56 | -3.60 |
Kinetik A | KNTK | Apr 30, 2024 | 38.34 | -2.49 |
Kingsoft Cloud ADR | KC | Apr 30, 2024 | 3.07 | -2.54 |
Kingstone Companies | KINS | Apr 30, 2024 | 4.50 | -1.53 |
Kingsway Financial Services | KFS | Apr 30, 2024 | 8.90 | -0.67 |
Kiniksa Pharmaceuticals A | KNSA | Apr 30, 2024 | 18.72 | +0.92 |
Kinnate Biopharma | KNTE | Apr 30, 2024 | 2.65 | 0.00 |
Kinross Gold | KGC | Apr 30, 2024 | 6.45 | -5.70 |
Kinsale Capital Group | KNSL | Apr 30, 2024 | 363.25 | +1.47 |
Kintara Therapeutics | KTRA | Apr 30, 2024 | 0.16 | -4.49 |
Kiora Pharmaceuticals | KPRX | Apr 30, 2024 | 0.50 | +4.25 |
Kirby | KEX | Apr 30, 2024 | 109.13 | -0.78 |
Kirklands | KIRK | Apr 30, 2024 | 1.91 | -2.05 |
Kite Realty Group Trust | KRG | Apr 30, 2024 | 21.80 | +0.46 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.